患者满意度与慢性疾病可预测腹主动脉瘤腔内修复术后监测依从性
该研究分析2010年1月1日至2014年12月31日接受EVAR的144例患者,89例(62%)依从最近一次推荐随访。对102例问卷分析显示,3年估计依从率为69.6±6.0%。对血管外科医生及住院体验不满意可预测不依从(HR 5.0),不依从组生存率较低但无动脉瘤相关死亡。
要点
- EVAR术后3年估计依从率为69.6±6.0%,144例中89例(62%)依从最近一次推荐随访。
- 对血管外科医生及住院体验不满意预测不依从(HR 5.0,95%CI 1.52-16.7,P=.008)。
- 不依从组3年及5年生存率均较低,但非依从组死亡均非动脉瘤相关。
核心结论
- 患者对血管外科医生及住院体验的满意度可预测EVAR术后监测依从性,与术后并发症无关。
- 不依从患者生存率降低,但死亡和监测不依从可能归因于致残性慢性疾病。
研究设计与样本
- 分析2010年1月1日至2014年12月31日在本中心接受EVAR的144例患者,从计算机注册系统、病历和电话问卷收集28个患者变量。
- 依从定义为在规定时间内完成最近一次推荐的随访监测检查。
- EVAR术后监测方案为术后1周、6个月及此后每年在本中心认证的无创血管实验室进行门诊评估和多普勒超声检查。
- 仅在多普勒超声提示内漏、瘤囊增大超过5 mm或分支支架失效时行CT血管造影。
- 102例患者完成问卷(患者死亡或失能时由家属完成),其中80例依从、22例不依从。
主要发现
- 144例接受EVAR的患者中,89例(62%)依从最近一次推荐随访。
- 基于102例问卷的Kaplan-Meier分析,EVAR术后3年估计依从率为69.6±6.0%。
- 依从组 vs 不依从组的估计3年生存率为93.2±3.4% vs 52.4±12.7%(P<.001)。
- 依从组 vs 不依从组的估计5年生存率为83.1±6.4% vs 34.4±13.4%(P<.001)。
- 多因素Cox回归分析显示,EVAR后不良神经事件有预测5年后不依从的趋势(HR 2.57,95%CI 0.95-6.90,P=.062)。
关键数值与推荐
- 对血管外科医生及住院体验不满意预测不依从推荐术后监测(HR 5.0,95%CI 1.52-16.7,P=.008)。
- 大学教育或更高学历与依从相关(HR 0.28,95%CI 0.06-1.23,P=.092)。
- 术后并发症或离医院距离等其他变量均未预测随访不依从。
- 不依从组观察到的死亡均非动脉瘤相关。
临床怎么用
- 血管外科学会推荐EVAR术后终身监测。
- 本研究中心EVAR术后监测方案为术后1周、6个月及此后每年进行门诊评估和多普勒超声检查。
- 本研究中心仅在多普勒超声提示内漏、瘤囊增大超过5 mm或分支支架失效时行CT血管造影。
- 作者指出患者对血管外科医生及住院体验的满意度可预测EVAR术后监测依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although lifelong surveillance is recommended by the Society for Vascular Surgery for patients undergoing endovascular aneurysm repair (EVAR) reported that compliance with long-term follow-up has been poor. We sought to identify factors that predict compliance with EVAR surveillance through analysis of patient variables and post-EVAR questionnaire results. METHODS: We analyzed 28 patient variables gathered from our computerized registry, patient charts, and phone questionnaires of patients who underwent EVAR between January 1, 2010, and December 31, 2014. These factors included patient demographics, education, postoperative complications, satisfaction with vascular surgery care, transportation mode, distance to our medical center, and living situation. Compliance was defined as a patient who underwent the most recent recommended follow-up surveillance study within the prescribed timeframe. Post-EVAR surveillance protocol consisted of office evaluation and duplex ultrasound examination performed in our accredited noninvasive vascular laboratory at 1 week, 6 months, then annually. Computed tomography angiography was obtained only if duplex ultrasound examination suggested endoleak, sac enlargement of more than 5 mm, or a failing limb. RESULTS: Of 144 patients who underwent EVAR during this time period, 89 patients (62%) were compliant with the most recent recommended follow-up study. One hundred two patients completed the questionnaire or their families did if patients died or were incapacitated. Of those, 80 were compliant with follow-up and 22 were not. Based on the questionnaires of these 102 patients, estimated compliance at 3 years after EVAR was 69.6 ± 6.0% based on Kaplan-Meier analysis. In the compliant vs noncompliant groups, the estimated 3-year survival rate was 93.2 ± 3.4% vs 52.4 ± 12.7%, respectively (P < .001), and the estimated 5-year survival rate was 83.1 ± 6.4% vs 34.4 ± 13.4%, respectively (P < .001), respectively. However, none of the mortalities observed in the noncompliant group were aneurysm related. Adverse neurologic events after EVAR demonstrated a trend predicting noncompliance after 5 years based on multivariate Cox regression analysis (hazard ratio [HR], 2.57; 95% confidence interval [CI], 0.95-6.90; P = .062). Patient dissatisfaction with their vascular surgeon and hospital care predicted noncompliance with recommended postoperative surveillance (HR, 5.0; 95% CI, 1.52-16.7; P = .008). College education or higher was associated with compliance (HR, 0.28; 95% CI, 0.06-1.23; P = .092). No other variables, including postoperative complications or distance from the hospital, predicted follow-up noncompliance. CONCLUSIONS: Patient satisfaction with their vascular surgeon and hospital experience predicted compliance with post-EVAR surveillance regardless of postoperative complications. Noncompliant patients had decreased survival, but mortality and surveillance noncompliance were likely due to disabling chronic disease.
引用
- Tyagi SC, Calligaro KD, Fukuhara S, et al. Patient satisfaction and chronic illness are predictors of postendovascular aneurysm repair surveillance compliance. J Vasc Surg. 2018. PMID: 30301686. doi:10.1016/j.jvs.2018.06.206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。